In addition to the effect of GSK-3β on proliferation and inhibition of apoptosis, GSK-3β phosphorylates/inhibits Cyclase-Associated Protein 1 (CAP-1), leading to increased migration and invasion of pancreatic cancer cells [51]. Here, CAP1 is linked to pancreatic neoplasm.